ACTRN12617001571369尚未招募不适用
Effect of Stereotactic ablative body radiotherapy for Unresectable Pancreatic cancer with Endoscopic ultrasound inserted fiducial markers and concuRrent chemotherapy on survival rates: SUPER trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerprostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
已完成
不适用
The efficacy of stereotactic body radiation therapy for unresectable hepatocellular carcinoma: a single institution phase II studyKCT0000625Asan Medical Center50
招募中
2 期
Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) Using Flattening Filter Free (FFF) in Early Non-small Cell Lung Cancers (NSCLC) and Metastatic Lung Cancers.early non-small cell lung cancerlung metastaseslung metastasesSBRT lungFlattening filter freeFFFsmall cell lung cancerTCTR20171127003none138
已完成
Unknown
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.Hepatocellular carcinomaJPRN-UMIN000051712Yokohama City University Medical Center
已完成
2 期
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20